Gilead Sciences
GILD
$66.76
Share price
0.91%
Change (1 day)
-20.63%
Change (1 year)
Categories
Earnings for Gilead Sciences (GILD)
Earnings in 2023 (TTM): $6.85 B
According to Gilead Sciences's latest financial reports the company's current earnings (TTM) are $6.85 B. In 2022 the company made an earning of $5.81 B a decrease over its 2021 earnings that were of $8.27 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Gilead Sciences from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $6.85 B | 17.97% |
| 2022 | $5.81 B | -29.77% |
| 2021 | $8.27 B | 395.99% |
| 2020 | $1.66 B | -67.66% |
| 2019 | $5.16 B | -33.84% |
| 2018 | $7.79 B | -42.35% |
| 2017 | $13.52 B | -20.87% |
| 2016 | $17.09 B | -21.06% |
| 2015 | $21.65 B | 45.8% |
| 2014 | $14.85 B | 253.01% |
| 2013 | $4.20 B | 16.51% |
| 2012 | $3.61 B | -1.07% |
| 2011 | $3.65 B | -6.71% |
| 2010 | $3.91 B | 11.75% |
| 2009 | $3.50 B | 29.5% |
| 2008 | $2.70 B | 19.11% |
| 2007 | $2.27 B | -455.74% |
| 2006 | -$0.64 B | -154.93% |
| 2005 | $1.16 B | 76.99% |
| 2004 | $0.65 B | -266.16% |
| 2003 | -$0.4 B | -638.24% |
| 2002 | $73.39 M | 31.5% |
| 2001 | $55.81 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | 147.44% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | -52.37% | 🇺🇸 USA |
 AbbVie ABBV | $6.25 B | -8.88% | 🇺🇸 USA |
 Eli Lilly LLY | $6.55 B | -4.44% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | 14.52% | 🇺🇸 USA |
 Biogen BIIB | $1.29 B | -81.09% | 🇺🇸 USA |
 Illumina ILMN | -$1.04 B | -115.16% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $4.42 B | -35.50% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -55.75% | 🇺🇸 USA |